What are the recommended loading and maintenance doses of phenytoin (Eptoin) for intravenous and intramuscular administration in adults and children?

Phenytoin (Eptoin) Dosing for Status Epilepticus

For status epilepticus in adults, administer a loading dose of 15-20 mg/kg IV at a rate not exceeding 50 mg/minute, followed by maintenance doses of 100 mg IV or orally every 6-8 hours; in children, use 15-20 mg/kg IV at 1-3 mg/kg/min (or 50 mg/min, whichever is slower). 1

Loading Dose Administration

Adults

• Loading dose: 15-20 mg/kg IV (some sources cite 10-15 mg/kg, but 15-20 mg/kg is preferred for status epilepticus) 1
• Infusion rate: Maximum 50 mg/minute 2, 1
• Time required: Approximately 20 minutes for a 70-kg patient 1
• Target serum level: 10-20 mcg/mL total phenytoin (1-2 mcg/mL unbound) 1

Pediatric Patients

• Loading dose: 15-20 mg/kg IV 2, 1
• Infusion rate: 1-3 mg/kg/min OR 50 mg/min, whichever is slower 2, 1
• Neonates: 10 mg/kg IV (phenobarbital is preferred in this age group due to increased toxicity risk from decreased protein binding) 2

Infusion Preparation and Administration

• Dilution: Must be diluted in normal saline only; final concentration ≥5 mg/mL 1
• Incompatibility: Never use dextrose-containing solutions—causes precipitation 2, 1
• In-line filter: Use 0.22-0.55 micron filter 1
• Timing: Complete infusion within 1-4 hours of preparation 1
• Flush: Follow each injection with sterile saline flush through same catheter 1

Maintenance Dosing

After Loading Dose

• Adults: 100 mg IV or PO every 6-8 hours 1
• Pediatric: Adjust based on serum levels; typical maintenance 4-7 mg/kg/day divided 3
• Monitor: Serum phenytoin levels to guide dosing adjustments 1

Critical Monitoring Requirements

Continuous monitoring during and after infusion is mandatory 1:

• Electrocardiogram (ECG) monitoring
• Blood pressure
• Respiratory function
• Heart rate (reduce infusion rate if heart rate decreases by 10 beats/min) 2

Important Caveats and Pitfalls

Route-Specific Warnings

Intramuscular administration should NOT be used for status epilepticus 1—peak serum levels may take up to 24 hours, making it ineffective for acute seizure control. IM route causes erratic absorption, necrosis risk, and abscess formation 1.

If IM administration is absolutely necessary (non-emergent situations only):

• Requires 50% higher dose than oral to maintain therapeutic levels 1
• When switching back to oral, reduce dose by 50% for one week to prevent toxicity from sustained IM release 1

Cardiovascular Risks

• Hypotension and arrhythmias are the primary risks, especially with rapid infusion 2
• If 50% QRS widening or hypotension occurs, stop the infusion immediately 2
• Fosphenytoin is preferred when available due to lower cardiac adverse effect risk 2

Special Populations

Renal/hepatic impairment or hypoalbuminemia: Monitor unbound (free) phenytoin concentrations rather than total levels, as the fraction of unbound drug is increased 1

Efficacy Limitations

Phenytoin alone may not terminate status epilepticus in all cases 1. The evidence shows:

• Only 56% success rate when diazepam followed by phenytoin 4
• Control rates of 36-64% in severe cases 5
• Concomitant benzodiazepines are usually necessary for rapid seizure control due to phenytoin's required slow administration rate 1

If phenytoin fails to control seizures, consider:

• IV benzodiazepines (lorazepam preferred) 6
• Alternative agents: valproate, levetiracetam, or phenobarbital 4
• Anesthetic doses of midazolam, propofol, or barbiturates for refractory cases 4

Drug Interactions

Avoid combining with amiodarone or other QT-prolonging drugs without expert consultation 2